| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
476 |
| issn |
1479-1641
1752-8984 |
| issueIdentifier |
6 |
| pageRange |
475-476 |
| publicationName |
Diabetes and Vascular Disease Research |
| startingPage |
475 |
| bibliographicCitation |
Ajjan R. Primary vascular prevention: The end of the road for aspirin? Diabetes and Vascular Disease Research. 2018 Nov;15(6):475–6. doi: 10.1177/1479164118807988. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0da9a452a53d7e700b69947db85a8271 |
| date |
201811 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/30415566
https://doi.org/10.1177/1479164118807988 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1752-8984
https://portal.issn.org/resource/ISSN/1479-1641
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32626 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Primary vascular prevention: The end of the road for aspirin? |
| discusses |
http://id.nlm.nih.gov/mesh/M0001864
http://id.nlm.nih.gov/mesh/M0017012 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D011322Q000379
http://id.nlm.nih.gov/mesh/D001241Q000627
http://id.nlm.nih.gov/mesh/D003925Q000517
http://id.nlm.nih.gov/mesh/D003920Q000188
http://id.nlm.nih.gov/mesh/D010975Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D003925Q000175
http://id.nlm.nih.gov/mesh/D019317
http://id.nlm.nih.gov/mesh/D003925Q000453
http://id.nlm.nih.gov/mesh/D001241Q000009
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D002986
http://id.nlm.nih.gov/mesh/D003920Q000453
http://id.nlm.nih.gov/mesh/D012307
http://id.nlm.nih.gov/mesh/D065840
http://id.nlm.nih.gov/mesh/D003920Q000175
http://id.nlm.nih.gov/mesh/D010975Q000009
http://id.nlm.nih.gov/mesh/D013997 |